Andrew Bedford
Directeur/Membre du Conseil chez Blu Homes, Inc.
Profil
Andrew Bedford currently works at Blu Homes, Inc., as Director and Skyhawk Therapeutics, Inc., as Director.
Postes actifs de Andrew Bedford
| Sociétés | Poste | Début |
|---|---|---|
Blu Homes, Inc.
 Blu Homes, Inc. HomebuildingConsumer Durables Blu Homes, Inc. designs and builds architect-designed, green precision-built prefab homes for residential, commercial, and institutional buyers. The company was founded by William M. Haney, III, Dennis Michaud, and Maura G. McCarthy in 2008 and is headquartered in Vallejo, CA. | Directeur/Membre du Conseil | - |
Skyhawk Therapeutics, Inc.
 Skyhawk Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Skyhawk Therapeutics, Inc. discovers and develops small molecule therapeutics for RNA-based disease. It is developing drug candidates for cancer, neurological disease, and rare disease. The company was founded by William M. Hanley III and Kathleen McCarthy and is headquartered in Waltham, MA. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Blu Homes, Inc.
Blu Homes, Inc. HomebuildingConsumer Durables Blu Homes, Inc. designs and builds architect-designed, green precision-built prefab homes for residential, commercial, and institutional buyers. The company was founded by William M. Haney, III, Dennis Michaud, and Maura G. McCarthy in 2008 and is headquartered in Vallejo, CA. | Consumer Durables |
Skyhawk Therapeutics, Inc.
Skyhawk Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Skyhawk Therapeutics, Inc. discovers and develops small molecule therapeutics for RNA-based disease. It is developing drug candidates for cancer, neurological disease, and rare disease. The company was founded by William M. Hanley III and Kathleen McCarthy and is headquartered in Waltham, MA. | Health Technology |
